ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PTCT PTC Therapeutics Inc

36.47
-0.73 (-1.96%)
May 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 710,232
Bid Price 34.71
Ask Price 38.80
News (1)
Day High 37.755

Low
17.53

52 Week Range

High
45.68

Day Low 36.25
Share Name Share Symbol Market Stock Type
PTC Therapeutics Inc PTCT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.73 -1.96% 36.47 19:00:00
Open Price Low Price High Price Close Price Previous Close
37.575 36.25 37.755 36.47 37.20
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
12,823 710,232 US$ 36.93 US$ 26,231,636 - 17.53 - 45.68
Last Trade Type Quantity Price Currency
15:01:48 priorref 144 US$ 36.47 USD

PTC Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.79B 76.61M - 1.07B -626.6M -8.18 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

PTC Therapeutics News

Date Time Source News Article
5/28/202407:30PR Newswire (US)PTC Therapeutics Announces Validation of Sepiapterin..
5/24/202416:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/22/202409:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/20/202411:20PR Newswire (US)PTC Therapeutics Announces European Commission Returns..
5/20/202406:20Edgar (US Regulatory)Form 8-K - Current report
5/20/202406:00PR Newswire (US)PTC Therapeutics Announces European Commission Returns..
5/14/202406:30PR Newswire (US)PTC Therapeutics Announces FDA Acceptance and Priority..
5/10/202416:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202416:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/07/202414:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/02/202407:00PR Newswire (US)PTC Therapeutics to Participate at Upcoming Investor..
4/25/202415:05PR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports First..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PTCT Message Board. Create One! See More Posts on PTCT Message Board See More Message Board Posts

Historical PTCT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week39.9240.6936.2538.19949,309-3.45-8.64%
1 Month31.9640.6930.70535.07909,4744.5114.11%
3 Months30.7140.6923.99530.55880,4855.7618.76%
6 Months21.3840.6921.1028.541,003,43215.0970.58%
1 Year42.4945.6817.5328.751,035,223-6.02-14.17%
3 Years39.4259.8417.5336.35772,697-2.95-7.48%
5 Years39.8570.8217.5340.82719,260-3.38-8.48%

PTC Therapeutics Description

PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Your Recent History

Delayed Upgrade Clock